Published 2 years ago

One Of Lilly's Most Anticipated Drugs Could Hit The Market In 2023

Summary by Investor's Business Daily

Eli Lilly said Thursday it plans to begin the process of asking the FDA to approve its obesity treatment. LLY stock rose on the news.

0 Articles

All

Left

Center

Right

Eli Lilly said Thursday it plans to begin the process of asking the FDA to approve its obesity treatment. LLY stock rose on the news.

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Ground News Article Assistant

Not enough coverage to generate an Article Assistant.

Total News Sources0

Leaning Left0Leaning Right1Center0Last Updated2 years agoBias Distribution

100% Right

100% Right

Factuality

To view factuality data please Upgrade to Premium

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)